Literature DB >> 12447291

Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial.

Till Wehrmann1, Jörg Grotkamp, Nikos Stergiou, Andrea Riphaus, Annegret Kluge, Bernhard Lembcke, Arthur Schultz.   

Abstract

BACKGROUND: Endoscopy with the patient under sedation with propofol requires careful monitoring of patient consciousness and vital signs to achieve the desired hypnotic effect without overdosage. Because level of consciousness is difficult to judge by clinical observation alone, electroencephalogram monitoring has been used to guide general anesthesia.
METHODS: Eighty consecutive patients (mean [SD] age 62 [14] years) undergoing ERCP for various indications were randomly allocated to 2 groups. In group A (n = 40), propofol sedation was guided by conventional monitoring (heart rate, blood pressure, oxygen saturation, electrocardiogram), whereas electroencephalogram monitoring was performed but not displayed to the physician who administered the drug. In group B (n = 40), electroencephalogram monitoring was displayed online and used to guide propofol administration to maintain a preselected sedation level. Procedure-related parameters, recovery time, and quality (postanesthesia recovery score), as well as patient cooperation and tolerance for the procedure (visual analog scale) were prospectively assessed.
RESULTS: The groups were comparable with regard to demographic, clinical, and procedure-related parameters. Mean propofol dose was significantly lower in group B than in group A (respectively, 290 [158] mg vs. 374 [166] mg; p = 0.02). The mean decrease in arterial blood pressure was significantly lower in group B than in group A (respectively, 11 [6] mm Hg vs. 14 [7] mm Hg; p < 0.05). Clinically relevant changes in vital signs to below critical values were observed in both groups, albeit infrequently. Efficacy of sedation was also rated similar in both groups, whereas mean recovery time was significantly faster in group B than in group A (respectively, 16 [7] minutes vs. 20 [8] minutes; p = 0.02). Accordingly, the recovery score tended to be better in group B compared with group A (respectively, 8.4 [1.0] points vs. 8.0 [0.9] points; p = 0.06). The predefined target level of sedation was maintained during 75% of the procedure time in group B but in only 58% of the time in group A (p < 0.05), and deeper sedation levels were achieved significantly more often in group B patients compared with group A patients (p < 0.05).
CONCLUSION: Electroencephalogram monitoring enables more effective titration of propofol dosage for sedation during endoscopy and is, therefore, associated with faster patient recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447291     DOI: 10.1067/mge.2002.129603

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  16 in total

Review 1.  Endoscopist-directed propofol: pros and cons.

Authors:  Eun Hye Kim; Sang Kil Lee
Journal:  Clin Endosc       Date:  2014-03-31

2.  Deep sedation for endoscopic retrograde cholangiopacreatography.

Authors:  Irene G Chainaki; Maria M Manolaraki; Gregorios A Paspatis
Journal:  World J Gastrointest Endosc       Date:  2011-02-16

Review 3.  How best to approach endoscopic sedation?

Authors:  Michaela Müller; Till Wehrmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-12       Impact factor: 46.802

Review 4.  Safety of Non-anesthesia Provider-Administered Propofol (NAAP) Sedation in Advanced Gastrointestinal Endoscopic Procedures: Comparative Meta-Analysis of Pooled Results.

Authors:  Basavana Gouda Goudra; Preet Mohinder Singh; Gowri Gouda; Anuradha Borle; Divakara Gouda; Amulya Dravida; Vinay Chandrashakhara
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

5.  Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection.

Authors:  Shinsuke Kiriyama; Takuji Gotoda; Hiromi Sano; Ichiro Oda; Fumiya Nishimoto; Tetsuro Hirashima; Chika Kusano; Hiroyuki Kuwano
Journal:  J Gastroenterol       Date:  2010-03-13       Impact factor: 7.527

6.  Gastroduodenal stenting.

Authors:  Derrick F Martin; Hans-Ulrich Laasch
Journal:  Semin Intervent Radiol       Date:  2004-09       Impact factor: 1.513

7.  BIS Targeted Propofol Sparing Effects of Dexmedetomidine Versus Ketamine in Outpatient ERCP: A Prospective Randomised Controlled Trial.

Authors:  Seshadri Ramkiran; Sadasivan S Iyer; Sudhindra Dharmavaram; Chadalavada Venkata Rama Mohan; Avinash Balekudru; Radhika Kunnavil
Journal:  J Clin Diagn Res       Date:  2015-05-01

8.  Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound: a prospective, randomized controlled trial.

Authors:  John M DeWitt
Journal:  Dig Dis Sci       Date:  2008-02-15       Impact factor: 3.199

9.  Bispectral index monitoring as an adjunct to nurse-administered combined sedation during endoscopic retrograde cholangiopancreatography.

Authors:  Se Young Jang; Hyun Gu Park; Min Kyu Jung; Chang Min Cho; Soo Young Park; Seong Woo Jeon; Won Young Tak; Young Oh Kweon; Sung Kook Kim; Young Hoon Jeon
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

10.  Ketamine, propofol and low dose remifentanil versus propofol and remifentanil for ERCP outside the operating room: is ketamine not only a "rescue drug"?

Authors:  Lea Paola Fabbri; Maria Nucera; Massimo Marsili; Mohamed Al Malyan; Chiara Becchi
Journal:  Med Sci Monit       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.